Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: donpat who wrote (1831)	3/9/2010 9:48:31 AM
From: xcentral1	Respond to of 12871

"Off balance sheet, Dr. Seymour estimates that the United States government and its various agencies have invested what could be worth 10 to 15 million dollars testing Nanoviricides’ Theracour© technology. These factors should be considered by those who see the company’s low book value per share as well as its approximate 132 million outstanding shares." See - the advantage of working with the various Governments!